Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biotelemetry Inc (BEAT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 917,203
  • Shares Outstanding, K 32,410
  • Annual Sales, $ 208,330 K
  • Annual Income, $ 53,440 K
  • 36-Month Beta 0.53
  • Price/Sales 4.32
  • Price/Cash Flow 20.20
  • Price/Book 3.35

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.84 +18.05%
on 11/15/17
30.50 -7.70%
on 11/30/17
+2.30 (+8.90%)
since 11/13/17
3-Month
23.30 +20.82%
on 11/13/17
37.70 -25.33%
on 09/14/17
-9.05 (-24.33%)
since 09/13/17
52-Week
20.65 +36.32%
on 12/15/16
39.20 -28.19%
on 09/11/17
+7.05 (+33.41%)
since 12/13/16

Most Recent Stories

More News
Multi-Billion Dollar Global Medical Device Industry Led by Cardiovascular Monitoring Devices

Global revenues for the medical device market are already a multi-billion dollar industry and the sector aims to continue its growth through leverage created through mergers and acquisitions, as well as...

LNB.CN : 0.600 (+3.45%)
NCI : 19.22 (+0.26%)
LXGTF : 0.4635 (-1.32%)
MDGL : 81.08 (+0.37%)
BEAT : 28.15 (-0.53%)
VTGN : 1.17 (-0.85%)
IMMU : 12.23 (+0.91%)
BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo

BioTelemetry (BEAT) progresses with deals to strengthen hold in the high-potential diabetes care market.

PETS : 45.05 (+3.54%)
MYGN : 33.27 (+2.12%)
LMNX : 20.52 (+0.64%)
BEAT : 28.15 (-0.53%)
BioTelemetry Ties Up With Apple, Grows in Cardiac Monitoring

BioTelemetry (BEAT) is consistently trying to improve its position in the cardiac monitoring and diagnostic services space.

PETS : 45.05 (+3.54%)
MYGN : 33.27 (+2.12%)
LMNX : 20.52 (+0.64%)
BEAT : 28.15 (-0.53%)
BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple's Heart Study

BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced...

AAPL : 172.27 (+0.33%)
BEAT : 28.15 (-0.53%)
Telcare, a Division of BioTelemetry, Inc., Announces Collaboration with Onduo in Diabetes Management Program

(NASDAQ:BEAT) - Telcare, the manufacturer of the world's first FDA-cleared cellular-enabled blood glucose monitor, has entered into a strategic collaboration with Onduo, a joint venture created by Verily...

BEAT : 28.15 (-0.53%)
With Latest Update, FDA Approval Soon Could Send BTCY Ripping

Response to US FDA Request Met, BTCY Could be Right Around the Corner From an FDA Clearance by Year-End, Likelihood of Approval is High

EKSO : 2.32 (-9.38%)
F : 12.63 (+0.24%)
BTCY : 4.9500 (+43.48%)
BEAT : 28.15 (-0.53%)
IRTC : 51.85 (-0.56%)
NKTR : 56.63 (+3.21%)
BMY : 63.47 (+0.30%)
Medical Research Stocks on Investors' Radar -- Organovo, BioTelemetry, Bruker, and PerkinElmer

If you want a Stock Review on ONVO, BEAT, BRKR, or PKI then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Monday, November 13, 2017, US markets saw...

BRKR : 34.19 (-0.26%)
BEAT : 28.15 (-0.53%)
ONVO : 1.42 (+2.90%)
PKI : 71.31 (+0.27%)
BioTelemetry (BEAT) Q3 Earnings Miss, Revenues Meet Estimates

A decline in gross and operating margin was a major drag for BioTelemetry (BEAT) in the third quarter.

PETS : 45.05 (+3.54%)
MYGN : 33.27 (+2.12%)
LMNX : 20.52 (+0.64%)
BEAT : 28.15 (-0.53%)
BioTelemetry, Inc. Reports Third Quarter 2017 Financial Results

Company Posts Strong Growth with Integration Ahead of Schedule

BEAT : 28.15 (-0.53%)
BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017

BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2017 earnings on Tuesday, November 7 at 4:00 PM Eastern Time.

BEAT : 28.15 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health. It is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. BioTelemetry, Inc., formerly known as CardioNet, Inc., is headquartered...

See More

Key Turning Points

2nd Resistance Point 29.05
1st Resistance Point 28.60
Last Price 28.15
1st Support Level 27.85
2nd Support Level 27.55

See More

52-Week High 39.20
Fibonacci 61.8% 32.11
Fibonacci 50% 29.92
Last Price 28.15
Fibonacci 38.2% 27.74
52-Week Low 20.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.